Evaluation of Pimobendan and N-Terminal Probrain Natriuretic Peptide in the Treatment of Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease in Dogs-Reference-Cited by-同舟云学术

Evaluation of Pimobendan and N-Terminal Probrain Natriuretic Peptide in the Treatment of Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease in Dogs

Published:2009-11 Issue:6 Volume:23 Page:1190-1196
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:

Author:

Atkinson K.J.,Fine D.M.,Thombs L.A.,Gorelick J.J.,Durham H.E.

Publisher

Wiley

Subject

General Veterinary

Reference46 articles.

1. 1.â Johnson L , Boon J , Orton EC. Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992â1996. J Vet Intern Med 1999;13:440â447.

2. 2.â Serres FJ , Chetboul V , Tissier R , et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001â2005). J Am Vet Med Assoc 2006;229:1772â1778.

3. 3.â Johnson L. Diagnosis of pulmonary hypertension. Clin Tech Small Anim Pract 1999;14:231â236.

4. Pulmonary Hypertension

5. 5.â Chatterjee K , De Marco T , Alpert JS. Pulmonary hypertension: Hemodynamic diagnosis and management. Arch Intern Med 2002;162:1925â1933.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?;Parasites & Vectors;2023-08-17

2. Pimobendan;Small Animal Critical Care Medicine;2023

3. Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020;Animals;2022-01-16

4. Effectiveness of therapy with low-dosage masitinib on pulmonary hypertension in dogs: a pilot study;Acta Veterinaria Brno;2022

5. The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study;BMC Veterinary Research;2021-09-25